Introduction of a chemical constraint in a short peptide derived from human acidic fibroblast growth factor elicits mitogenic structural determinants

Journal of Medicinal Chemistry

Volumn 46, Issue 12, 2003, Pages 2325-2333

  Kiyota, Sumika ^a   Franzoni, Lorella ^c   Nicastro, Giuseppe ^c   Benedetti, Arianna ^c   Oyama Jr , Sérgio ^a,b   Viviani, Wládia ^a   Gambarini, Angelo G ^a   Spisni, Alberto ^b,c   Miranda, M Terêsa M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF PARMA   (Italy)

^c LABORATÓRIO NACIONAL DE LUZ SÍNCROTRON   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINYLLYSYLLYSYLHISTIDYLCYSTEINYLGLUTAMINYLLYSYLASPARAGINYLTRYPTOP HYLPHENYLALANINAMIDE; ACIDIC FIBROBLAST GROWTH FACTOR; PEPTIDE; SERYLLYSYLLYSYLHISTIDYLALANYLGLUTAMINYLLYSYLASPARAGINYLTRYPTOPHYLPHENYLALAN INAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; MITOGENICITY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PROTEIN BINDING; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; STRUCTURE ACTIVITY RELATION;

3T3 CELLS; ANIMALS; CIRCULAR DICHROISM; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTORS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MITOGENS; MODELS, MOLECULAR; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; PROTEIN CONFORMATION; THYMIDINE;

EID: 0038101402     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm020543e     Document Type: Article

References (67)

1. Manetti, F.; Corelli, F.; Botta, M. Fibroblast growth factors and their inhibitors. Curr. Pharm. Des. 2000, 6, 1897-1924.
2. Burgess, W. H.; Maciag, T. The heparin-binding (fibroblast growth factor) family of proteins. Annu. Rev. Biochem. 1989, 58, 575-606.
3. Baird, A.; Klagsbrun, M. The fibroblast growth factor family. Cancer Cells 1990, 3, 239-243.
4. Folkman, J.; Klagsbrun, M. Angiogenic factors. Science 1987, 235, 442-447.
5. Jaye, M.; Schlessinger, J.; Dionne, C. A. Fibroblast growth factor receptor tyrosine kninases: molecular analysis and signal transduction. Biochim. Biophys. Acta 1992, 1135, 185-199.
6. Ulrich, A.; Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990, 61, 203-212.
7. McKeehan, W. L.; Wang, F.; Kan, M. The heparan sulfatefibroblast growth factor family: diversity of structure and function. Prog. Nucleic Acid Res. Mol. Biol. 1998, 59, 135-173.
8. Folkman, J.; Klagsbrun, M.; Sasse, J.; Wadzinski, M.; Ingber, D.; Vlodavsky, I. A heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement-membrane. Am. J. Pathol. 1988, 130, 393-400.
9. Vlodavsky, I. Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem. Sci. 1991, 16, 268-271.
10. Gospodarowicz, D.; Cheng, J. Heparin protects basic and acidic fibroblast growth factors from inactivation. J. Cell. Physiol. 1986, 128, 475-484.
11. Sommer, A.; Rifkin, D. B. Interaction of heparin with human basic fibroblast growth factor: protection of the angiogenic protein from proteolytic degradation by glucosaminoglycan. J. Cell. Physiol. 1989, 138, 215-220.
12. Ornitz, D. M.; Herr, H. B.; Nilsson, M.; Westman, J.; Svahn, C. M.; Waksman, G. FGF binding and FGF receptor activation by synthetic heparan-derived di- and tri-saccharides. Science 1995, 268, 432-436.
13. Casu, B.; Guerrini, M.; Naggi, A.; Perez, M.; Torri, G.; Ribatti, D.; Carminati, P.; Giannini, G.; Penco, S.; Pisano, C.; Belleri, M.; Rusnati, M.; Presta, M. Short Heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors. Biochemistry 2002, 41, 10519-10528
14. Pantoliano, M. W.; Horlick, R. A.; Springer, B. A.; Van Dyk, D. E.; Tobery, T.; Wetmore, D. R.; Lear, J. D.; Nahapetian, A. T.; Bradley, J. D.; Sysk, W. P. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry 1994, 33, 10229-19248.
15. Springer, B. A.; Pantoliano, M. W.; Barbera, F. A.; Gunyulzu, P. L.; Thompson, L. D.; Herblin, W. F.; Rosenfeld, S. A.; Book, G. W. Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis. J. Biol. Chem. 1994, 269, 26879-26884.
16. Oyama, S., Jr.; Miranda, M. T. M.; Kiyota, S.; Gambarini, A. G. Molecular modeling as a powerful tool for the mapping of fibroblast growth factor receptor-1 ligand binding determinants. J. Mol. Model. 1999, 5, 90-96.
17. Di Gabrielli, A. D.; Lax, I.; Chen, D. I.; Svahn, C. M.; Jaye, M.; Schlessinger, J.; Hendrickson, W. A. Structure of a heparin-like biologically active dimmer of fibroblast growth factor. Nature 1998, 393, 812-817.
18. Ventakaran, G.; Raman, R.; Sasisekharan, V.; Sasisekharan, R. Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 3658-3663.
19. Huhtala, M. T.; Penkainen, O.; Johnson, M. S. A dimeric ternary complex of FGFR1, heparin and FGF-1 leads to an "electrostatic sandwich" model for heparin binding. Structure 1999, 7, 699-709.
20. Stauber, D. J.; DiGabriele, A. D.; Hendrickson, W. A. Structural interaction of fibroblast growth factor receptor with its ligands. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 49-54.
21. Kan, M.; Wang, F.; Xu, J.; Crabb, J. W.; Hou, J.; McKeehan, W. L. An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 1993, 259, 1918-1921.
22. Blaber, M.; DiSalvo, J.; Thomas, K. A. X-ray crystal structure of human acidic fibroblast growth factor. Biochemistry 1996, 35, 2086-2094.
23. Ogura, K.; Nagata, K.; Hatanaka, H.; Habuchi, H.; Kimata, K.; Tate, S.-I.; Ravera, W. R.; Jaye, M.; Schlessinger, J.; Inagaki, F. Solution structure of human acidic fibroblast growth factor and interaction with heparin-derived hexasaccharide. J. Biomol. NMR 1999, 13, 11-24.
24. Reich-Slottky, R.; Shaoul, E.; Berman, B.; Graziani, G.; Ron, D. Chimeric molecules between keratinocyte growth factor and basic fibroblast growth factor define domains that confer receptor binding specificity. J. Biol. Chem. 1995, 270, 29813-29818.
25. Pellegrini, L.; Burke, D. F.; von Delft, F.; Mulloy, B.; Blundell, T. L. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 2000, 407, 1029-1034.
26. Oyama, S., Jr.; Miranda, M. T. M.; Toma, I. N.; Viviani, W.; Gambarinin, A. Mitogenic activity of peptides related to the sequence of human fibroblast growth factor-1. Biochem. Mol. Biol. Int. 1996, 39, 1237-1244.
27. Brych, S. R.; Blaber, S. I.; Logan, T. M.; Blaber, M. Structure and stability effects of mutations designed to increase the primary sequence symmetry within the core region of a b-trefoil. Protein Sci. 2001, 10, 2587-2599.
28. Wüthrich, K. NMR of Proteins and Nucleic Acids; John Wiley & Sons: New York, 1986.
29. Kelly, L. A.; Gardner, S. P.; Sutcliffe, M. J. An automated approach for clustering an ensemble of NMR-derived structures into conformationally related subfamilies. Protein Eng. 1996, 9, 1063-1065.
30. Moult, J.; Melamud, E. From fold to function. Curr. Opin. Struct. Biol. 2000, 10, 384-389.
31. Sanz, J. M.; Jiménez, M. A.; Giméenez-Gallego, G. Hints of nonhierarchical folding of acidic fibroblast growth factor. Biochemistry 2002, 41, 1923-1933.
32. Chung, D. A.; Zuiderweg, E. R. P.; Fowler, C. B.; Soyer, O. S.; Mosberg, H. I.; Neubig, R. R. NMR structure of the second intracellular loop of the α2A-adrenergic receptor: evidence for a novel cytoplasmic helix. Biochemistry 2002, 41, 3596-3604.
33. Naider, F.; Arshava, B.; Ding, F-X.; Arevalo, E.; Becker, J. M. Peptide fragments as models to study the structure of a G-protein coupled receptor: the alfa-factor receptor of Sacharomices cerevisiae. Biopolymers 2001, 60, 334-350.
34. Chamberlin, S. G.; Sargood, K. J.; Richter, A.; Mellor, J. M.; Anderson, D. W.; Richards, N. G. J.; Turner, D. L.; Sharma, R. P.; Alexander, P.; Davies, D. E. Constrained peptide analogues of transforming growth factor-a residues cysteine 21-32 are mitogenically active. J. Biol. Chem. 1995, 270, 21062-21067.
35. Rizo, J.; Sutton, R. B.; Breslau, J.; Koerber, S. C.; Porter, J.; Hagler, A. T.; Rivier, J. E.; Gierasch, L. M. A novel conformation in a highly potent, constrained gonadotropin-releasing hormone antagonist. J. Am. Chem. Soc. 1996, 118, 970-976.
36. Schwyzer, R. 100 years lock-and-key concept: are peptide keys shaped and guided to their receptors by target cell membrane? Biopolymers 1995, 37, 5-16.
37. Ruan, K.-H.; So, S.-P.; Wu, J.; Huang, A.; Kung, J. Solution structure of the second extracellular loop of human thromboxane A2 receptor. Biochemistry 2001, 40, 275-280.
38. Nicastro, G.; Peri, F.; Franzoni, L.; de Chiara, C.; Sartor, G.; Spisni, A. Conformational Features of a Synthetic Model of the First Extracellular Loop of the Angiotensin II AT1A Receptor. J. Pept. Sci., in press.
39. Bottaro, D. P.; Fortney, E.; Rubin, J. S.; Aaronson, S. A. A keratinocyte growth factor receptor-derived peptide antagonist identifies part of the ligand binding site. J. Biol. Chem. 1993, 268, 9180-9183.
40. Yayon, A.; Aziezer, D.; Safran, M.; Gross, J. L.; Heldmann, Y.; Cabilly, S.; Givol, D.; Katchalski-Ktzir, E. Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 10643-10647.
41. Wong, P.; Hampton, B.; Szylobryt, E.; Gallagher, A. M.; Jaye, M.; Burgess, W. H. Analysis of putative heparin-binding domains of fibroblast growth factor-1. J. Biol. Chem. 1995, 270, 25805-25811.
42. Fromm, J. R.; Hileman, H. E.; Weiler, J. M.; Linhardt, R. J. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides. Arch. Biochem. Biophys. 1997, 346, 252-262.
43. Kiyota, S.; Gambarini, A. G.; Viviani, W.; Oyama, S., Jr.; Toma, I. N.; Sykes, B. D.; Miranda, M. T. M. New synthetic peptides derived from human fibroblast growth factor-1: search for agonists and inhibitors. In Peptides: Frontiers of Peptide Science; Proceedings of the 15th American Peptide Symposium, Nashville, TN, June 14-19, 1999; Tam, J. P., Kaumaya, P. T. P., Eds.; ESCOM/Kluwer: Dordrecht, The Netherlands, 1999; pp 641-642.
44. Flaumenhaft, R.; Moscatelli, D.; Rifkin, D. B. Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor. J. Cell. Biol. 1990, 111, 1651-1659.
45. Thompson, L. D.; Pantoliano, M. W.; Springer, B. A. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. Biochemistry 1994, 33, 3831-3840.
46. Ballinger, M. D.; Venkatakrishna, S.; Forrest, L. D.; Deuter-Reinhard, M.; Doyle, L. V.; Wang, J.-X.; Panganiban-Lustan, L.; Stratton, J. R.; Apell, G.; Winter, J. A.; Doyle, M. V.; Rosenberg, S.; Kavanaugh, W. M. Semirational design of a potent, artifical agonist of fibroblast growth factor receptors. Nat. Biotechnol. 1999, 17, 1199-1204.
47. DeLano, W. L.; Ultsch, M. H.; de Vos, A. M.; Wells, J. A. Convergent solutions to binding at a protein-protein interface. Science 2000, 287, 1279-1282.
48. Hu, Z.; Ma, B.; Wolfson, H.; Nussinov, R. Conservation of polar residues as hot spots at protein interfaces. Proteins: Struct., Funct., Genet. 2000, 39, 331-342.
49. Zhu, Z.; Komiya, H.; Chirino, A.; Faham, S.; Fox, G. M.; Arakawa, T. A. A.; Hsu, B. T.; Rees, D. C. Three-dimensional structures of acidic and basic fibroblast growth factors. Science 1991, 251, 90-93.
50. Plotnikov, A. N.; Schlessinger, J.; Hubbard, S. R.; Mohammadi, M. Structural basis for FGF receptor dimerization and activation. Cell 1999, 98, 641-650.
51. Murzin, A. G.; Lesk, A. M.; Chothia, C. b-Trefoil fold-patterns of structures and sequence in the Kunitz inhibitors, intrleukins-1b and 1a and fibroblast growth factors. J. Mol. Biol. 1992, 233, 531-543.
52. Faham, S.; Hileman, R. E.; Fromm, J. R.; Linhardt, R. J.; Rees, D. C. Heparin structure and interactions with basic fibroblast growth factor. Science 1996, 271, 1116-1120.
53. Pineda-Lucena, A.; Jiménez, M. A.; Lozano, R. M.; Nielo, J. L.; Santoro, J.; Rico, M.; Giménez-Gallego, G. Three-dimensional structure of acidic fibroblast growth factor in solution: effects of binding to a heparin functional analog. J. Mol. Biol. 1996, 264, 162-178.
54. Varanda, L. M.; Miranda, M. T. M. Solid-phase peptide synthesis at elevated temperatures: a search for an optimized synthesis condition of unsulfated cholecystokinin-12. J. Pept. Res. 1997, 50, 102-108.
55. Misicka, A.; Hruby, V. J. Optimization of disulfide bond formation. Pol. J. Chem. 1994, 68, 893-99.
56. Miranda, M. T. M.; Liddle, R. A.; Rivier, J. E. Synthesis of human CCK 26-33 and CCK-33 related analogs on 2,4-DMBHA and TMBHA. J. Med. Chem. 1993, 36, 1681-1688.
57. Armelin, H. A. Pituitary extracts and steroid hormones in the control of 3T3 cell growth. Proc. Natl. Acad. Sci. U.S.A. 1973, 70, 2702-2706.
58. Shing, Y.; Folkman, J.; Sullivan; R.; Butterfield, C.; Murray, J.; Klagsbrun, M. Heparin-affinity: purification of a tumor derived capillary endothelial cell growth factor. Science 1984, 223, 1296-1298.
59. Kan, M.; Shi, E. G.; Mckeehan, W. L. Identification and assay of fibroblast growth factor receptors. Methods Enzymol. 1991, 198, 159-171.
60. 1H NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 1983, 117, 479-485.
61. Davis, D. G.; Bax, A. Assignment of complex proton NMR spectra via two-dimensional homonuclear Hartmann-Hahn spectroscopy. J. Am. Chem. Soc. 1985, 107, 2820-2821.
62. Bax, A.; Davis, D. G. Practical aspects of two-dimensional transverse NOE spectroscopy. J. Magn. Reson. 1985, 63, 207-213.
63. Kumar, A.; Ernst, R. R.; Wüthrich, K. A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochem. Biophys. Res. Commun. 1980, 95, 1-6.
64. States, D. J.; Haberkorn, R. A.; Ruben, D. J. A two-dimensional nuclear Overhauser experiment with pure absorption phase in four quadrants. J. Magn. Res. 1982, 48, 286-292.
65. Kim, Y.; Prestegard, J. H. Measurement of vicinal couplings from cross peaks in COSY spectra. J. Magn. Res. 1989, 84, 9-13.
66. Dauber-Osguthorpe, P.; Roberts, V. A.; Osguthorpe, D. J.; Wolff, D. J.; Genest, M.; Hagler, A. T. Structure and energetics of ligand binding to proteins: E. coli dihydrofolate reductase-trimethoprim, a drug-receptor system. Proteins: Struct., Funct., Genet. 1988, 4, 31-47.
67. Nilges, M.; Clore, G. M.; Gronenborn, A. Determination of three-dimensional structures of proteins from interproton distance data by dynamical simulated annealing from a random array of atoms. Circumventing problems associated with folding. FEBS Lett. 1998, 239, 129-136.